Drug Shortage Report for BIO-AMLODIPINE
Report ID | 147158 |
Drug Identification Number | 02392135 |
Brand name | BIO-AMLODIPINE |
Common or Proper name | AMLODIPINE |
Company Name | BIOMED PHARMA |
Market Status | MARKETED |
Active Ingredient(s) | AMLODIPINE |
Strength(s) | 5MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 100 |
ATC code | C08CA |
ATC description | SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF. |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | |
Actual start date | 2021-10-13 |
Estimated end date | |
Actual end date | 2021-10-25 |
Shortage status | Resolved |
Updated date | 2021-10-26 |
Company comments | Nous gardons le format de 500 |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 9450 BOUL. LANGELIER MONTREAL, QUEBEC CANADA H1P 3H8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2021-10-26 | English | Compare |
v4 | 2021-10-25 | French | Compare |
v3 | 2021-10-25 | English | Compare |
v2 | 2021-10-14 | French | Compare |
v1 | 2021-10-14 | English | Compare |
Showing 1 to 5 of 5